CP and bathing suit ichthyosis: As previously shown, the introduction of ceftazidime/avibactam probably led to a sudden and significant shift (p < 0.001) in the epidemiology of CP-Kp in the ICU from KPC-producing isolates to MBL-producing ones, mainly due to the resurrection of VIM-producing isolates, which had not caused a BSI in the hospital during 2015–17 [9].